publication date: Dec. 21, 2010
In this issue:
ASCO Ends Early Distribution Of Abstracts To Halt “ASCO Effect” On Stock Market;
Bush Appoints Lander To NCAB;
IOM Report Links Agent Orange, CLL;
FDA Puts Clinical Hold On Gene Therapy Trials;
US Oncology Clarifies Role of Pharmacy Committee;
Download (PDF 258KB)
To access this members-only content, please log in.
Institutional subscribers, please log in with your IP
If you're not a subscriber why not join today?
To gain access to the members only content click here
You will be given immediate access to premium content on the site.Click here to join.